Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: EPOPROSTENOL — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved the original ANDA for epoprostenol from Sun Pharmaceutical Industries, Inc., confirming a generic version of the pulmonary arterial hypertension th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epoprostenol (Epoprostenol)

Snippet

ORIG AP for EPOPROSTENOL (EPOPROSTENOL)